Related Experiment Video
Updated: Aug 14, 2026

07:59
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Special Issue "Advancements in Cancer Biomarkers"
Michael Hannides1, Christos Mikropoulos1
1Clinical Oncology, Royal Surrey NHS Foundation Trust, Egerton Road, Surrey, Guildford GU2 7XX, UK.
International Journal of Molecular Sciences
|August 13, 2026
Summary
This Special Issue highlights new cancer biomarker research, offering insights into molecular oncology advancements. Discover the latest developments in early detection and personalized cancer treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer biomarker research is crucial for early detection, diagnosis, and treatment monitoring.
- The field of molecular oncology is rapidly evolving with new discoveries.
- An updated perspective on cancer biomarkers is needed.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...